What ails India's pharmaceutical sector?
Posted by
www.biotecnika.org
Unlike mature markets such as the US, where drug prices are
market-controlled, here, the government and regulators play a pivotal
role in the entire process. Regulators fix both the price companies
pay for bulk drugs and the price at which they sell their products in
the market, leaving little leeway to earn profit. For Indian pharma,
this is a double-edged sword.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/what-ails-indias-pharmaceutical-sector/articleshow/73339737.cms
Subscribe to:
Post Comments (Atom)
Post a Comment